Gillian Vandekerkhove

University of British Columbia (UBC)

2329 West Mall

Vancouver, British Columbia BC V6T 1Z4

Canada

SCHOLARLY PAPERS

1

DOWNLOADS

63

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Randomized Phase 1 Trial of Pembrolizumab with Neo-Adjuvant Versus Concomitant Stereotactic Body Radiotherapy in Metastatic Urothelial Carcinoma

Number of pages: 85 Posted: 11 Oct 2018
Nora Sundahl, Gillian Vandekerkhove, Karel Decaestecke, Annabel Meireson, Pieter De Visschere, Valérie Fonteyne, Daan De Maeseneer, Dries Reynders, Els Goetghebeur, Jo Van Dorpe, Sofie Verbeke, Matti Annala, Lieve Brochez, Kim Van der Eecken, Alexander W. Wyatt, Sylvie Rottey and Piet Ost
Ghent University - Department of Radiation Oncology and Experimental Cancer Research, University of British Columbia (UBC), Ghent University, Ghent University - Ghent University Hospital, Ghent University - Ghent University Hospital, Ghent University - Department of Radiation Oncology and Experimental Cancer Research, Ghent University - Ghent University Hospital, Ghent University - Department of Applied Mathematics and Computer Science, Ghent University - Department of Applied Mathematics and Computer Science, Ghent University - Ghent University Hospital, Ghent University - Ghent University Hospital, University of British Columbia (UBC), Ghent University - Ghent University Hospital, Ghent University - Ghent University Hospital, University of British Columbia (UBC), Ghent University - Ghent University Hospital and Ghent University - Department of Radiation Oncology and Experimental Cancer Research
Downloads 63 (632,749)

Abstract:

Loading...

metastatic urothelial carcinoma, checkpoint inhibitors, stereotactic body radiotherapy, phase 1 trial, pembrolizumab